TL;DR
A US supplement brand qualifies a raw-material supplier by setting its own component specification, then approving documented identity, regulatory status, batch test evidence, contaminant controls, traceability, and change control. For dietary ingredients, the manufacturer must verify identity before use; a supplier CoA alone cannot replace that duty.
A US supplement brand should qualify a nutraceutical raw-material supplier through 8 approval gates: specification, regulatory fit, CoA reliability, risk controls, traceability, quality systems, first-order controls, and monitoring. For each dietary ingredient, the manufacturer that uses it must conduct at least 1 appropriate identity test or examination before use, unless FDA grants an exemption. 21 CFR 111.75
Use the checklist before you approve a sample, issue a purchase order, or add a supplier to an approved list.
What a Supplier Must Prove
A supplier must prove that its material matches your written specification and that its documentation can support your receiving and release process.
Your team sets the requirements first. Under 21 CFR 111.70, a dietary-supplement manufacturer must establish component specifications for identity, needed purity, strength, composition, and relevant contamination limits.
A supplier's reputation, catalogue, or certificate does not replace that specification. Start every supplier review by naming the exact material, grade, dosage form, target use level, and material risks.
Supplier Qualification Checklist for US Supplement Brands
Assign one owner to every row. A supplier becomes approved only when the evidence and acceptance rule are complete.
| Gate | Evidence and Pass Rule | Owner | Follow-Up Action |
|---|---|---|---|
| Supplier map | Maker, site, role, grade match approved specification | Purchasing + QA | Pause approval, send questionnaire |
| Identity and specification | Identity plan covers purity, strength, composition, contaminants | QA + formulation | Revise specification or reject |
| Regulatory fit | NDI status and intended-use safety basis documented | Regulatory affairs | Hold launch for review |
| CoA reliability | Lot CoA includes method, limits, results, QC confirmation | QC + QA | Test independently, correct dossier |
| Risk controls | Applicable microbes, metals, solvents, pesticides addressed | QC + QA | Quarantine and investigate |
| Traceability and allergens | Manufacturer-to-lot chain and allergen statement complete | QA + regulatory | Escalate origin or allergen gap |
| Quality system | Agreement covers changes, deviations, recalls, contacts | QA + legal | Conditional approval or audit |
| Monitoring | Risk-based review and change triggers documented | QA | Requalify, suspend, or remove |
The checklist separates a document request from an approval decision. A supplier may provide a polished CoA and still fail because the lot, method, source, or change-control record does not meet your specification.
Verify Identity and Specification Fit
Write the component specification before comparing suppliers. The specification is your pass-fail document, not the supplier's product sheet.
For a botanical, include the common name, Latin binomial, plant part, extraction solvent if relevant, extract ratio, carrier, physical form, and marker or assay requirement. For a vitamin, mineral, amino acid, or probiotic, define the exact chemical form, potency basis, particle or physical requirements, and storage conditions.
Then assign identity testing responsibility. FDA requires at least 1 appropriate identity test or examination for every dietary ingredient before use. A brand using a contract manufacturer should name that manufacturer in the quality agreement and confirm its receiving plan covers the material. FDA’s cGMP guide
Do not confuse an extract ratio with a potency result. “10:1” describes the relationship between starting botanical material and extract. It does not prove the percentage of a marker compound in the delivered lot.
Request These Test Reports and Documents
Request documents for a specific lot, then compare every result against your approved specification.
Ask for:
- A current specification sheet.
- A batch-specific Certificate of Analysis.
- Test methods and full results for required tests.
- Manufacturing date, retest date or expiry date, storage conditions, and packaging details.
- Safety Data Sheet.
- Manufacturer, manufacturing site, and country-of-origin declaration.
- Allergen and cross-contact statement.
- Change-control and recall contact details.
A usable CoA identifies the test method, acceptance limit, and actual result. If a manufacturer relies on a supplier CoA for specifications other than dietary-ingredient identity, it must first establish the CoA’s reliability, document qualification, periodically re-confirm it, and obtain quality-control approval. CoA requirements
“Conforms” is not enough when your specification needs a numeric result. Ask for the value, unit, method, and lot number that connects the report to the containers you receive.
Evaluate Origin, Traceability, and Allergen Controls
Traceability means your team can follow a delivered lot from your receiving dock to the manufacturer and the relevant source records.
Ask whether the supplier manufactures the material, distributes it, or brokers it. A distributor can be useful, but your qualification file should still identify the actual manufacturer and testing site. Ask for the country or region of origin when origin affects botanical identity, contaminant risk, lead time, or label positioning.
Review allergens before formula approval. FDA recognizes 9 major food allergens: milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans, and sesame. Sesame has required allergen declaration on packaged dietary supplements since January 1, 2023. FDA allergen rules
Request an allergen statement that covers intentional ingredients and relevant cross-contact controls. Give that statement to the regulatory owner before labels or “free-from” claims move forward.
If the ingredient may be new to the US dietary-supplement market, assign a regulatory review before sourcing. FDA requires a new dietary ingredient notification at least 75 days before interstate introduction when the notification requirement applies. FDA NDI process
Control the First Commercial Order
A commercial purchase order should repeat the approved material name, grade, specification version, packaging, storage condition, and required lot documents.
Keep the first delivery in quarantine until the receiving team checks the container label, lot number, seal condition, CoA, and required identity-testing path. A sample that met expectations does not release a different commercial lot.
Name the US importer before shipment for imported material. The applicable foreign supplier verification duties depend on who imports, who manufactures or processes the supplement, and who establishes the Part 111 specifications. FDA FSVP guidance
The first order should also activate the quality agreement. The agreement should require notice before a site, process, source, specification, method, carrier, or packaging change affects your material.
Monitor an Approved Supplier
Approval is a maintained status. Monitor whether incoming results continue to match the supplier CoA, whether deliveries arrive in specification, and whether the supplier reports changes on time.
Set the review interval by risk. A new botanical supplier, a material with a history of adulteration, or an ingredient with complex contaminant risks deserves more frequent confirmation than a well-characterized material with a clean record.
Trigger an immediate review when the supplier changes the manufacturing site, source region, sub-supplier, process, test method, specification, or carrier. Trigger the same review after an out-of-specification result, a complaint trend, a recall, or a traceability failure.
Use an approved-supplier list that records the material, manufacturer, site, approval date, risk level, required testing, and next review date. That record gives purchasing a clear answer: buy, hold, or find another source.
For a broader next step after qualification, read our guide to US nutraceutical ingredient suppliers. If your ingredient is a vitamin, also review origin documentation for bulk vitamins.
FAQs
Must a Supplement Brand Test Every Ingredient Lot Itself?
No. The manufacturer that uses the dietary ingredient must conduct the required identity test or examination before use. A brand working with a contract manufacturer should assign that responsibility in writing and review the manufacturer’s receiving controls.
What Proves a Botanical Extract Is the Ordered Material?
A complete identity package names the botanical’s Latin binomial, plant part, extract form, carrier, and marker or assay requirement. The incoming identity test then confirms the delivered lot matches that specification.
Who Handles FSVP for an Imported Ingredient?
The US importer must identify the applicable FSVP responsibilities before entry. FDA’s modified dietary-supplement requirements can apply differently when the importer or its customer establishes and verifies Part 111 specifications. FDA’s importer guidance
What Should a Quality Agreement Cover?
A quality agreement should assign ownership for specifications, testing, deviations, recalls, document retention, and change notifications. It should also state which changes require notice before the next lot ships.
At Aarise Pharmaceuticals, our CDMO overview explains our pharmaceutical product-development and commercial-manufacturing work for oral dosage forms. Use the completed checklist before moving from an ingredient inquiry to a sourcing discussion.
